Avid Diagnostics - About the company
Avid Diagnostics is an unfunded company based in Mumbai (India), founded in 2022. It operates as a Provider of pharmacogenetic testing platform for precision medicine. Avid Diagnostics has not raised any funding yet. The company has 158 active competitors, including 64 funded and 9 that have exited. Its top competitors include companies like Evotec, Insitro and DNAnexus.
Company Details
Provider of pharmacogenetic testing platform for precision medicine. It offers personalised prescription to optimize doses, reduce cost and time to accelerate the development of new medicines and improve global health outcomes.
- Website
- aviddiagnostics.com
- Email ID
- *****@aviddiagnostics.com
- Phone Number
- +91 **********
Key Metrics
Sign up to download Avid Diagnostics' company profile
Avid Diagnostics's funding and investors
Avid Diagnostics has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Avid Diagnostics's Competitors and alternates
Top competitors of Avid Diagnostics include Evotec, Insitro and DNAnexus. Here is the list of Top 10 competitors of Avid Diagnostics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of drug discovery alliance and development services for biopharma sector | $25M | 76/100 | ||
2nd |  Insitro 2018, San Francisco (United States), Series C | Developer of machine learning platform for drug discovery and development | $643M | 71/100 | |
3rd |  DNAnexus 2009, Mountain View (United States), Series H | Provider of cloud-based genome informatics & data management platform | $473M | 70/100 | |
4th | Cytel 1987, Cambridge (United States), Acquired | Provider of data analysis and statistical solutions for the life sciences industry | $2M | 66/100 | |
5th | Immunai Technologies 2018, United States, Series B | Developer of next-generation of immunomodulatory therapeutics | $295M | 66/100 | |
6th | Metagenomi 2016, Berkeley (United States), Public | Digital gene editing technologies for drug development | $376M | 65/100 | |
7th |  NewLimit 2022, San Francisco (United States), Series B | Developer of epigenetic reprogramming medicines for aging-related diseases and healthspan extension | $247M | 64/100 | |
8th |  Asimov 2017, Boston (United States), Series B | Provider of integrated suite for advanced genetic design and manufacturing | $209M | 64/100 | |
9th |  Relation Therapeutics 2020, London (United Kingdom), Seed | AI-based drug development tools for researchers | $116M | 63/100 | |
10th | _1569310612679.png?devicePixelRatio=2&height=30&width=30){kind=logo} Kinomica 2017, Macclesfield (United Kingdom), Series A | Provider of a bioinformatics platform for the development of precision medicine | $5.16M | 63/100 | |
115th | Avid Diagnostics 2022, Mumbai (India), Unfunded | Provider of pharmacogenetic testing platform for precision medicine | - | - | 24/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Avid Diagnostics's competitors? Click here to see the top ones
Avid Diagnostics's Investments and acquisitions
Avid Diagnostics has made no investments or acquisitions yet.
Reports related to Avid Diagnostics
Here is the latest report on Avid Diagnostics's sector:
Are you a Founder ?
FAQs about Avid Diagnostics
Explore our recently published companies
- Educativa - Bantul based, 2022 founded, Unfunded company
- RYSE Chocolate Energy - Ratoath based, 2024 founded, Unfunded company
- Veltos - Bengaluru based, 2023 founded, Unfunded company
- DeAge - Mumbai based, 2025 founded, Unfunded company
- CPC Analytics - Berlin based, 2014 founded, Unfunded company
- Grid - San Francisco based, 2024 founded, Funding Raised company
